Clinical trials
Acute Coronary Syndrome trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
91 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 11 |
| 2010 | 7 |
| 2011 | 9 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 63 |
| Terminated | 9 |
| Unknown status | 8 |
| Recruiting | 7 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Charite University, Berlin, Germany | 6 |
| Deutsches Herzzentrum Muenchen | 5 |
| GlaxoSmithKline | 4 |
| Bristol-Myers Squibb | 3 |
| Eli Lilly and Company | 3 |
| LMU Klinikum | 3 |
| RWTH Aachen University | 3 |
| Sanofi | 3 |
| Bayer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acute Coronary Syndrome | 91 |
| Coronary Artery Disease | 21 |
| Myocardial Infarction | 16 |
| Non-ST Elevated Myocardial Infarction | 12 |
| ST Elevation Myocardial Infarction | 11 |
| Cardiovascular Diseases | 7 |
| Stroke | 7 |
| Angina Pectoris | 6 |
| Angina, Unstable | 6 |
| Myocardial Ischemia | 6 |
Trials
Showing 51 to 75 of 91. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.